Abstract
C. albicans is by far the most common Candida species causing infection in humans which include superficial and a life- threatening systemic infections. Despite the public health significance of candida infections, phenotypic switching of C. albicans, slow mycological diagnosis, limitation of use of antifungal agents due to toxicity, high cost and emergence of resistance have impeded effective treatment. Therefore, a need for safe and potent strategy to prevent this disease is necessary. This chapter discusses the roles of white blood cells as the first line defense mechanism against inactivated C. albicans.
Reference33 articles.
1. Forsyth C. B. and Mathews, H. C. (2002). Lymphocytes adhesion to C. albicans. 70(2): 517-527
2. Martınez, J.P., Gil, M.L., Lopez-Ribot, J.L. and Chaffin, W.L. (1998) Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin. Microbiol. Rev. 11, 121-141
3. Staib P, Morschhäuser J. (2007). "Chlamydospore formation in Candida albicans and Candida dubliniensis an enigmatic developmental programme”. Mycoses 50 (1): 1-12. PMID 17302741
4. Levitz, S.M. (1992). Overview of host defenses in fungal infections. Clin. Infect. Dis. 14 (Suppl 1), S37–S42
5. Casadevall, A., Cassone, A., Bistoni, F., Cutler, J.E., Magliani, W., Murphy, J.W., et al., (1998). Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? Med. Mycol. 36, 95-105
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献